Hong Kong Stock Exchange's latest disclosures reveal that on September 23, CHINA STAR ENT (00326) experienced a notable position change, with the total market value of transferred shares amounting to HK$2.2 billion, representing 14.19% of the company's holdings.

A shareholder of the company transferred 340 million shares to RhinoX Limited, which were moved out from KINGSTON Securities. This significant transfer highlights a strategic reallocation of the company's shareholding structure.

Previously, CHINA STAR ENT (00326) released its interim results for the six months ending June 30, 2026. The company reported revenue of HK$95.314 million, a decrease of 62.84% compared to the same period last year. The loss attributable to owners of the company stood at HK$56.094 million, an improvement of 49.41% from the prior year. The loss per share was HK$0.0231.